Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration-resistant prostate cancer † † Presented in part at the 2019 GU ASCO and ASCO Annual Meeting (Halabi S, Dutta S, Chi KN, et al. PSA decline and objective response rates in White (W), Black (B), and Asian men with metastatic castration-resistant prostate cancer (mCRPC). J Clin Oncol. 2019;37(suppl; abstr 5021). https://doi.org/10.1200/JCO.2019.37.15_suppl.5021.).
Titel:
Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration-resistant prostate cancer † † Presented in part at the 2019 GU ASCO and ASCO Annual Meeting (Halabi S, Dutta S, Chi KN, et al. PSA decline and objective response rates in White (W), Black (B), and Asian men with metastatic castration-resistant prostate cancer (mCRPC). J Clin Oncol. 2019;37(suppl; abstr 5021). https://doi.org/10.1200/JCO.2019.37.15_suppl.5021.).
Auteur:
Halabi, S. Dutta, S. Tangen, C.M. Rosenthal, M. Petrylak, D.P. Thompson Jr., I.M. Chi, K.N. De Bono, J.S. Araujo, J.C. Logothetis, C. Eisenberger, M.A. Quinn, D.I. Fizazi, K. Morris, M.J. Higano, C.S. Tannock, I.F. Small, E.J. Kelly, W.K.